The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| PBIO | -96.67% | -99.97% | -80.33% | -100% |
| S&P | +18.37% | +110.18% | +16.02% | +875% |
Pressure BioSciences, Inc. engages in the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. The firm’s products include high pressure barocyclers and barozyme, high pressure generators and accessories, mini ultra-high pressure pump, barocycler and barozyme accessories, microtube accessories for barocyclers and barozyme, high pressure cell disruptors from constant systems, and service contracts. It offers its products under the brands Barocycler, PULSE, BioSeq, ProteoSolve, ProteoSolveLRS, Power of PCT, PCT Shredder, HUB440, HUB880, micro- Pestle, PCT-HD, BaroFold, Barozyme, BaroFlex and Strips. The company was founded by Richard T. Schumacher in August 1978 and is headquartered in South Easton, MA.
| Q2 2024 | YOY Change | |
|---|---|---|
| Revenue | $0.42M | 0.0% |
| Gross Profit | $0.04M | 0.0% |
| Gross Margin | 10.49% | 0.0% |
| Market Cap | $4.42M | 0.0% |
| Market Cap / Employee | $0.28M | 0.0% |
| Employees | 16 | 0.0% |
| Net Income | -$7.12M | 0.0% |
| EBITDA | -$1.84M | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2024 | YOY Change | |
|---|---|---|
| Net Cash | $0.01M | 0.0% |
| Accounts Receivable | $0.18M | 0.0% |
| Inventory | 0.5 | 0.0% |
| Q2 2024 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.52M | 0.0% |
| Short Term Debt | $28.67M | 0.0% |
| Q2 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -718.28% | 0.0% |
| Return On Invested Capital | 85.50% | 0.0% |
| Q2 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$0.71M | 0.0% |
| Operating Free Cash Flow | -$0.71M | 0.0% |
| Metric | Q4 2023 | Q1 2024 | Q2 2024 | YoY Change |
|---|---|---|---|---|
| Price to Book | -0.27 | -0.19 | -0.16 | - |
| Price to Sales | 5.90 | 4.40 | 4.37 | - |
| Price to Tangible Book Value | -0.27 | -0.19 | -0.14 | - |
| Enterprise Value to EBITDA | -10.24 | -27.74 | -19.43 | - |
| Total Debt | $23.89M | $32.10M | $29.19M | - |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
